US SB5226 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on September 25 2024 - 25% progression, died in committee
Action: 2024-09-25 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 25 2024 - 25% progression, died in committee
Action: 2024-09-25 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to establish a program to address sickle cell disease and other heritable hemoglobinopathies.
Title
Sickle Cell Disease Treatment Centers Act of 2024
Sponsors
Sen. Chris Van Hollen [D-MD] | Sen. Cory Booker [D-NJ] | Sen. Amy Klobuchar [D-MN] |
History
Date | Chamber | Action |
---|---|---|
2024-09-25 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB9872 (Same As) 2024-09-27 - Referred to the House Committee on Energy and Commerce.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/senate-bill/5226/all-info |
Text | https://www.congress.gov/118/bills/s5226/BILLS-118s5226is.pdf |